Drug Discovery and Development
In response, MMV and DNDi, in collaboration with scientists from industry and academia, created the Pandemic Response Box to encourage new research into pandemic disease treatments. The box will contain 400 structurally diverse compounds for screening against infectious and neglected diseases. Disease experts chose these 400 compounds with diverse mechanisms of action from a large list of antibacterial, antiviral, and antifungal compounds. They are all either already on the market or are in various stages of drug discovery or development. The biological activity of the compounds has not been confirmed by MMV/DNDi partners; the choice was made based on information available in the literature